Wealthcare Advisory Partners’s Tandem Diabetes Care TNDM Stock Holding History

Wealthcare Advisory Partners’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-250	Closed	-$22K	–	1745
2021 Q1	$22K	Buy	+250	New	+$23.2K	﹤0.01%	1178
2020 Q2	–	Sell	-250	Closed	-$16K	–	1253
2020 Q1	$16K	Hold	250	–	–	﹤0.01%	800
2019 Q4	$15K	Hold	250	–	–	﹤0.01%	845
2019 Q3	$15K	Hold	250	–	–	﹤0.01%	833
2019 Q2	$16K	Buy	+250	New	+$16.1K	﹤0.01%	788

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Wealthcare Advisory Partners's TNDM Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of Tandem Diabetes Care (TNDM) in Q2 2021, closing a stake of 250 shares — an estimated $22K sold.

Wealthcare Advisory Partners first reported a position in TNDM in Q2 2019 and held it in 5 quarters. The position peaked at $22K in Q1 2021. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2021.

Wealthcare Advisory Partners reported no remaining Tandem Diabetes Care position as of Q2 2021 after selling out during the quarter.
Wealthcare Advisory Partners sold 250 Tandem Diabetes Care shares in Q2 2021, an estimated $22K.
Wealthcare Advisory Partners first reported a position in Tandem Diabetes Care in Q2 2019 and held it in 5 quarters.
Wealthcare Advisory Partners's Tandem Diabetes Care position peaked at $22K in Q1 2021.
303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.